Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
393.72
Dollar change
-4.87
Percentage change
-1.22
%
Index- P/E- EPS (ttm)-5.17 Insider Own0.63% Shs Outstand59.19M Perf Week-0.80%
Market Cap23.35B Forward P/E95.91 EPS next Y4.10 Insider Trans0.00% Shs Float58.93M Perf Month-1.00%
Income-295.51M PEG- EPS next Q-0.75 Inst Own54.95% Short Float2.28% Perf Quarter1.86%
Sales1.23B P/S19.01 EPS this Y59.80% Inst Trans-7.17% Short Ratio3.85 Perf Half Y-17.60%
Book/sh69.22 P/B5.69 EPS next Y297.87% ROA-7.70% Short Interest1.34M Perf Year7.44%
Cash/sh53.62 P/C7.34 EPS next 5Y- ROE-8.55% 52W Range327.73 - 550.76 Perf YTD3.49%
Dividend Est.- P/FCF- EPS past 5Y-17.05% ROI-7.18% 52W High-28.51% Beta0.65
Dividend TTM- Quick Ratio9.01 Sales past 5Y287.78% Gross Margin81.59% 52W Low20.14% ATR (14)11.90
Dividend Ex-Date- Current Ratio9.75 EPS Y/Y TTM60.46% Oper. Margin-37.75% RSI (14)53.21 Volatility2.73% 2.66%
Employees1148 Debt/Eq0.00 Sales Y/Y TTM198.89% Profit Margin-24.06% Recom1.59 Target Price471.59
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q10.02% Payout- Rel Volume0.53 Prev Close398.59
Sales Surprise14.00% EPS Surprise-27.15% Sales Q/Q82.26% EarningsFeb 29 BMO Avg Volume348.58K Price393.72
SMA202.31% SMA501.74% SMA200-11.44% Trades Volume184,653 Change-1.22%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-20-23Downgrade William Blair Outperform → Mkt Perform
Dec-20-23Downgrade Deutsche Bank Buy → Hold
Jul-31-23Initiated Scotiabank Sector Perform $516
Jul-24-23Downgrade UBS Buy → Neutral $480 → $570
Jul-17-23Resumed Evercore ISI Outperform $436
Jun-15-23Initiated Societe Generale Sell
May-31-23Initiated UBS Buy $480
Apr-25-23Initiated Citigroup Buy $450
Mar-14-23Upgrade Robert W. Baird Neutral → Outperform $460
Mar-27-24 02:00AM
Mar-26-24 04:00PM
02:00AM
Mar-22-24 10:28AM
07:47AM
04:45PM Loading…
Mar-21-24 04:45PM
Mar-20-24 06:38PM
Mar-19-24 07:16AM
Mar-17-24 08:49AM
Mar-07-24 04:01PM
08:14AM
07:28AM
Mar-01-24 10:12AM
Feb-29-24 10:16PM
01:00AM
08:38AM Loading…
Feb-28-24 08:38AM
Feb-26-24 01:00AM
Feb-22-24 08:00AM
01:00AM
Feb-21-24 10:08PM
Feb-20-24 01:00AM
Jan-22-24 05:35AM
Jan-18-24 01:00AM
Jan-12-24 08:30AM
Jan-08-24 01:00AM
Jan-04-24 06:44PM
Jan-02-24 01:00AM
Dec-22-23 05:05AM
Dec-21-23 04:09PM
09:50AM
04:33PM Loading…
Dec-20-23 04:33PM
04:02PM
03:20PM
12:15PM
07:26AM
06:30AM
01:00AM
Dec-18-23 03:17AM
Dec-12-23 03:04PM
Dec-08-23 05:19AM
Dec-03-23 05:25AM
Dec-01-23 06:55AM
Nov-28-23 06:59PM
04:04PM
12:06PM
08:51AM
05:17AM
01:00AM
Nov-16-23 07:40AM
Nov-07-23 11:22AM
09:04AM
Nov-06-23 01:16PM
Nov-05-23 05:54PM
Nov-01-23 10:57PM
10:15AM
02:00AM
02:00AM
Oct-31-23 05:05PM
04:05PM
09:14AM
02:00AM
Oct-24-23 01:00AM
Oct-20-23 03:24AM
Oct-05-23 08:13AM
Sep-27-23 04:09PM
04:06PM
12:25PM
Sep-26-23 04:13PM
10:01AM
Sep-21-23 01:00AM
Sep-17-23 09:50AM
Sep-16-23 09:00AM
09:00AM
Sep-15-23 04:27PM
01:00AM
Aug-30-23 01:00AM
Aug-21-23 01:44AM
Aug-19-23 11:02AM
Aug-09-23 12:19PM
Jul-31-23 10:00AM
09:51AM
Jul-28-23 10:59AM
Jul-27-23 04:12PM
08:29AM
01:00AM
Jul-26-23 04:07PM
Jul-24-23 04:30PM
Jul-21-23 01:17PM
Jul-20-23 01:00AM
Jul-19-23 05:58PM
Jul-18-23 09:30PM
Jul-17-23 04:10PM
04:01PM
02:37PM
01:02PM
09:37AM
09:09AM
01:03AM
01:00AM
Jun-30-23 11:20AM
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands.